Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease

Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease

10.1002/alz.12332

Saved in:

Bibliographic Details
Main Authors:	Chong, Joyce R, Ashton, Nicholas J, Karikari, Thomas K, Tanaka, Tomotaka, Saridin, Francis N, Reilhac, Anthonin, Robins, Edward G, Nai, Ying-Hwey, Vrooman, Henri, Hilal, Saima, Zetterberg, Henrik, Blennow, Kaj, Lai, Mitchell KP, Chen, Christopher P
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	Wiley 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/188261
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease
by: Chong, JR, et al.
Published: (2023)

Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease
by: Xu, X., et al.
Published: (2022)

SERUM SEROTONIN IN COGNITIVE DECLINE, CEREBROVASCULAR DISEASE AND CEREBRAL ATROPHY
by: THONG HWAI KIT
Published: (2016)

Intracranial stenosis, cerebrovascular diseases, and cognitive impairment in Chinese
by: Hilal, Saima, et al.
Published: (2016)

Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia
by: Wu, Liu-Yun, et al.
Published: (2022)

Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances
by: Chong, Joyce R, et al.
Published: (2023)

Improved amyloid burden quantification with nonspecific estimates using deep learning
by: Liu, Haohui, et al.
Published: (2022)

RETINAL IMAGING IN CEREBROVASCULAR DISEASE AND DEMENTIA
by: ONG YI TING
Published: (2015)

Retinal vascular signs and cerebrovascular disease
by: Baker, M.L., et al.
Published: (2014)

Role of transcranial doppler ultrasonography in cerebrovascular disease
by: Yeo, L.L.L., et al.
Published: (2016)

Role of transcranial doppler ultrasonography in cerebrovascular disease
by: Ahmad, A., et al.
Published: (2016)

Menopause, hormone therapy and cardiovascular and cerebrovascular disease
by: Mattar, C.N., et al.
Published: (2011)

Alzheimer's disease with cerebrovascular disease: current status in the Asia–Pacific region
by: C. Chen, et al.
Published: (2018)

Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease
by: Vipin A., et al.
Published: (2020)

Associations of cardiac function and arterial stiffness with cerebrovascular disease
by: Tan, Chin Hong, et al.
Published: (2024)

COVID-19 and cerebrovascular diseases: a comprehensive overview
by: Tsivgoulis, Georgios, et al.
Published: (2021)

TNF RECEPTOR 1 SIGNALING IN CEREBROVASCULAR DISEASE AND NEURODEGENERATION
by: SALAI KAUNG HTET TUN
Published: (2023)

Arterial compliance and retinal vascular caliber in cerebrovascular disease
by: Cheung, N., et al.
Published: (2014)

Associations of cardiac function and arterial stiffness with cerebrovascular disease
by: TAN, Chin Hong., et al.
Published: (2024)

A case of Kawasaki Disease with concomitant leptospirosis
by: Foo, Caleb Chuan Yao, et al.
Published: (2021)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
by: Gallart-Palau, Xavier, et al.
Published: (2018)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
by: S. Tangwongchai, et al.
Published: (2018)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease
by: Gallart-Palau X., et al.
Published: (2018)

Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease
by: Ji F., et al.
Published: (2020)

Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular disease
by: Gallart-Palau, Xavier, et al.
Published: (2018)

Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease
by: Vipin, Ashwati, et al.
Published: (2022)

Intracranial metastases from unsuspected choriocarcinoma: Onset suggestive of cerebrovascular disease
by: Samruay Shuangshoti, et al.
Published: (2018)

Trends in mortality from hypertensive and cerebrovascular diseases in Singapore, 1959 to 1983
by: Hughes, K.
Published: (2016)

Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
by: Vorapun Senanarong, et al.
Published: (2018)

Intra-arterial digital subtraction angiography for suspected cerebrovascular disease--current status.
by: Hoe, J., et al.
Published: (2016)

Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases
by: Worawit Louthrenoo
Published: (2018)

Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases
by: Worawit Louthrenoo
Published: (2018)

Concomitant inheritance of α‐thalassemia in β°‐thalassemia/hb e disease
by: Pranee Winichagoon, et al.
Published: (2018)

Concomitant coronary artery disease among Asian ischaemic stroke patients
by: De Silva, D.A., et al.
Published: (2016)

Two-year vascular event rates in patients with symptomatic cerebrovascular disease: The reach registry
by: Venketasubramanian, N., et al.
Published: (2016)

Status Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.
by: Lin, Huimin, et al.
Published: (2023)

A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
by: Narasimhalu, K., et al.
Published: (2014)

Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: A slow-titration regimen
by: Nantika Thavichachart, et al.
Published: (2018)